| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A historical approach to hereditary spastic paraplegia
|
Walusinski, O.
|
|
|
176 |
4 |
p. 225-234
|
article
|
| 2 |
Another extensive nitrous oxide (N2O) myelopathy: The wood for the trees?
|
Demas, A.
|
|
|
176 |
4 |
p. 293-295
|
article
|
| 3 |
Benign hereditary chorea: From benign to serious
|
Lamiral, A.
|
|
|
176 |
4 |
p. 295-296
|
article
|
| 4 |
Covid-19, the pandemic war: Implication for neurologists
|
de Seze, J.
|
|
|
176 |
4 |
p. 223-224
|
article
|
| 5 |
Editorial Board
|
|
|
|
176 |
4 |
p. i
|
article
|
| 6 |
Fluoroquinolone-induced motor neuron hyperexcitability
|
Posener, S.
|
|
|
176 |
4 |
p. 296-298
|
article
|
| 7 |
Functional movement disorders
|
Galli, S.
|
|
|
176 |
4 |
p. 244-251
|
article
|
| 8 |
Impulse control disorder-linked hypersexuality complicated by disseminated gonococcal infection in a patient with Parkinson's disease
|
Moegle, C.
|
|
|
176 |
4 |
p. 292-293
|
article
|
| 9 |
Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies
|
Mejdoub, S.
|
|
|
176 |
4 |
p. 261-267
|
article
|
| 10 |
New modalities of prescription of ATUns: Evolutions and revolution
|
Vignot, S.
|
|
|
176 |
4 |
p. 290-292
|
article
|
| 11 |
Repair strategies for traumatic spinal cord injury, with special emphasis on novel biomaterial-based approaches
|
Soares, S.
|
|
|
176 |
4 |
p. 252-260
|
article
|
| 12 |
Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study
|
Blaise, A.-S.
|
|
|
176 |
4 |
p. 268-276
|
article
|
| 13 |
Serum cortisol levels in patients with a transient global amnesia
|
Schneckenburger, R.
|
|
|
176 |
4 |
p. 285-288
|
article
|
| 14 |
Sleep parameters associated with long-term outcome following subthalamic deep brain stimulation in Parkinson's disease
|
Torun, N.A.
|
|
|
176 |
4 |
p. 277-284
|
article
|
| 15 |
Tumefactive demyelinating lesions after initiating fingolimod in patient with multiple sclerosis: A case report
|
Navardi, S.
|
|
|
176 |
4 |
p. 289-290
|
article
|
| 16 |
What are the infectious risks with disease-modifying drugs for multiple sclerosis and how to reduce them? A review of literature
|
Pourcher, V.
|
|
|
176 |
4 |
p. 235-243
|
article
|
Journal description